Immuno's ambitious plans
Investors should be wary of Immunodiagnostic Systems' (IDH:AIM) plan to double revenues in five years due to development and financial risk.The Tyne & Wear-based company, which makes manual and automated diagnostic testing kits...
03 July 2014
